http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1735051-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14f3116515434baeb016d47c79c28e9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-39622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3962
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-368
filingDate 2005-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0459cc77fc034d99b4d106dc9a887233
publicationDate 2006-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1735051-A1
titleOfInvention Device for hemodynamic stabilization during tachycardias
abstract Implantable device, in particular implantable cardioverter-defibrillator, for responding to tachycardia events in a patient's heart comprising a control device, a first interface connected to said control device for receiving first signals representative of tachycardia events and connectable to a first sensor device for detecting tachycardia events, a second interface connected to said control device and connectable to a first stimulation electrode, and said control device being arranged for providing at least one stimulation pulse to said second interface in response to at least one of said first signals received at said second interface for responding to tachycardia events, wherein said control device is arranged for providing at least one first stimulation pulse to said second interface upon continued presence of said first signals at said first interface for at least intermittently improving the cardiac output during continued tachycardia events.
priorityDate 2004-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005101998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5243980-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6442425-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128238201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135843816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043

Total number of triples: 28.